Alejandro Velez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alejandro Velez has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
- Ana Patricia Estrada-Florez
Genome Center UC‐Davis Davis California USA
17 shared publications - Bizu Gelaye
Epidemiology Branch, Division of Population Health Research, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institutes of Health Bethesda Maryland USA
17 shared publications - Carlos A. Castaneda
Instituto Nacional de Enfermedades Neoplasicas 2 , Lima, Peru
17 shared publications - Christopher A. Haiman
Department of Preventive Medicine, Keck School of Medicine of USC, Los Angeles, USA
17 shared publications - David V. Conti
Center for Genetic Epidemiology, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California
17 shared publications - Donglei Hu
Department of Medicine, University of California, San Francisco, San Francisco, USA
17 shared publications
Latest Publications
- 17 March 2025
- Published by Oxford University Press (OUP) in Modern Rheumatology Case Reports
- Vol. 9 (2)
Neurosarcoidosis or granulomatosis with polyangiitis? A complex case of a brain mass
Sarcoidosis is an immune-mediated systemic disease characterised by the presence of non-caseating granulomas in various parts of the body in the absence of another defined aetiology. Neurologic involvement [neurosarcoidosis (NS)], which occurs in 5–10% of patients with the disease, encompasses a range of clinical and histopathological manifestations that can lead to significant morbidity and mortality. We present a case of a young man with a history of chronic sinusitis, who developed sudden headache associated with seizures. After thorough clinical and paraclinical evaluation, the diagnosis of NS was made once other neurovascular, infectious, metabolic, tumour-related, and immune-mediated aetiologies were ruled out. NS can present as a large dural mass due to nodular pachymeningitis, which can be clinically indistinguishable from other entities such as neoplasms and granulomatosis with polyangiitis. Isolated central nervous system involvement in this entity is rare and usually it is associated with other systemic manifestations. More aggressive management is required to treat this form of sarcoidosis presentation. NS represents a diagnostic challenge and requires ruling out more common entities such as infectious and non-infectious causes like granulomatosis with polyangiitis.
- 17 March 2025
- Published by Oxford University Press (OUP) in Modern Rheumatology Case Reports
- Vol. 9 (2)
Neurosarcoidosis or granulomatosis with polyangiitis? A complex case of a brain mass
Sarcoidosis is an immune-mediated systemic disease characterised by the presence of non-caseating granulomas in various parts of the body in the absence of another defined aetiology. Neurologic involvement [neurosarcoidosis (NS)], which occurs in 5–10% of patients with the disease, encompasses a range of clinical and histopathological manifestations that can lead to significant morbidity and mortality. We present a case of a young man with a history of chronic sinusitis, who developed sudden headache associated with seizures. After thorough clinical and paraclinical evaluation, the diagnosis of NS was made once other neurovascular, infectious, metabolic, tumour-related, and immune-mediated aetiologies were ruled out. NS can present as a large dural mass due to nodular pachymeningitis, which can be clinically indistinguishable from other entities such as neoplasms and granulomatosis with polyangiitis. Isolated central nervous system involvement in this entity is rare and usually it is associated with other systemic manifestations. More aggressive management is required to treat this form of sarcoidosis presentation. NS represents a diagnostic challenge and requires ruling out more common entities such as infectious and non-infectious causes like granulomatosis with polyangiitis.
- Open Access
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Table S4 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Table S4 shows a list of polymorphisms in the PRS panels with association analyses summary statistics from 7 pooled Hispanic/Latino datasets.
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table S4 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Table S4 shows a list of polymorphisms in the PRS panels with association analyses summary statistics from 7 pooled Hispanic/Latino datasets.
- Open Access
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S1 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Figure S1 shows global ancestry distribution of individuals by countries across seven studies included in this analysis.
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S1 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Figure S1 shows global ancestry distribution of individuals by countries across seven studies included in this analysis.
- Open Access
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Table S6 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Table S6 shows two-sided Hosmer-Lemeshow P values for calibration of the PRS panels tested in our datasets.
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table S6 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Table S6 shows two-sided Hosmer-Lemeshow P values for calibration of the PRS panels tested in our datasets.
- Open Access
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S4 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Figure S4 shows effect of adding only one H/L SNP to European PRS panels on performance in H/L samples.
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S4 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Figure S4 shows effect of adding only one H/L SNP to European PRS panels on performance in H/L samples.
- Open Access
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Table S8 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Table S8 shows comparisons of performance of the PRS panel for different pair of ranges of Indigenous American (IA) ancestry.
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table S8 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Table S8 shows comparisons of performance of the PRS panel for different pair of ranges of Indigenous American (IA) ancestry.
- Open Access
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Table S2 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Table S2 shows performance of PRS panels constructed from PRS3820 European panel plus 2 H/L SNPs using different imputation r2 cutoffs.
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table S2 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Table S2 shows performance of PRS panels constructed from PRS3820 European panel plus 2 H/L SNPs using different imputation r2 cutoffs.
- Open Access
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Table S7 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Table S7 shows comparisons of performance for the PRS panel pairs in different ranges of Indigenous American (IA) ancestry.
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table S7 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Table S7 shows comparisons of performance for the PRS panel pairs in different ranges of Indigenous American (IA) ancestry.
- Open Access
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Table S3 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Table S3 shows sample sizes in the Indigenous American ancestry ranges selected for our analysis.
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table S3 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Table S3 shows sample sizes in the Indigenous American ancestry ranges selected for our analysis.
- Open Access
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S2 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Figure S2 shows performance of PRS panels with addition of 2 or 3 H/L SNPs
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S2 from Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage
Supplemental Figure S2 shows performance of PRS panels with addition of 2 or 3 H/L SNPs